Nontuberculous mycobacterial pulmonary diseases (NTM-PD) are increasingly recognised as opportunistic infections of humans. Nodular/bronchiectatic disease and fibrocavitary disease are the most frequent manifestations [1]. Although guidelines have been published [1], there are few data on diagnostic and treatment practices outside of reference clinics. A recent survey in the USA suggested limited adherence to guidelines for diagnosis and treatment of NTM-PD [2]. Poor adherence to diagnosis and treatment guidelines for nontuberculous mycobacterial lung disease in EU and Japan
No takes yet. Share an insight, caveat, or question.
Ingen et al. (2016) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: